·   Log in

Archive for December, 2009

Once-daily weight loss pill Qnexa by Vivus under regulatory review in US

Thursday, December 31, 2009 23:52

Qnexa, an once-daily formulation to aid weight loss, is under regulatory review in US, Vivus, Inc annonced in a press release.

This was posted under category: health  |  Read Full Story  |  0 Comments
Tagged with:

Blood test to detect appendicitis AppyScore is coming: AspenBio Pharma

Thursday, December 31, 2009 23:52

AppyScore will the first-ever blood test to diagnose appendicitis, if approved

This was posted under category: medical devices  |  Read Full Story  |  0 Comments
Tagged with:

US FDA delays pneumococcal vaccine Prevnar 13 approval: Pfizer

Thursday, December 31, 2009 23:51

Prevnar vaccine was implicated in the death of an infant in a clinical trial in India

This was posted under category: Biotech  |  Read Full Story  |  0 Comments
Tagged with: ,

Medicinal plants exports from India zoom

Thursday, December 31, 2009 23:51

India now ranks the world's second largest exporter of medicinal plants after China as the trade in herbals registered around 20% growth in last finacial year, according to reports.

This was posted under category: Extra, Featured  |  Read Full Story  |  0 Comments

India to buy 1.5 million doses of H1N1 swine flu vaccine from Sanofi Pasteur: Reports

Wednesday, December 30, 2009 21:47

Sanofi Pastuer recalled 800,000 pre-filled syringes of Influenza A (H1N1) 2009 Monovalent Vaccine for kids from US market on potency problems

This was posted under category: Biotech, Featured  |  Read Full Story  |  0 Comments

OTC lotion to treat cold sores NB-001 to enter US, Canada

Wednesday, December 30, 2009 19:51

NB-001, a novel topical over-the-counter (OTC) treatment for cold sores (herpes labialis), may soon hit the markets in US and Canada.

This was posted under category: Clinical Trials, Consumer  |  Read Full Story  |  0 Comments
Tagged with: ,

New epilepsy drug retigabine under FDA review in US

Wednesday, December 30, 2009 15:19

Retigabine, a new treatment for adult epilepsy patients with partial-onset seizures, has been accepted for review by US FDA.

This was posted under category: Clinical Trials  |  Read Full Story  |  0 Comments

Novo Nordisk’s diabetes drug liraglutide (Victoza) FDA approval delayed in US

Wednesday, December 30, 2009 13:57

Victoza could be a potential block-buster to treat diabetes and obesity if approved, believes Novo

This was posted under category: Industry  |  Read Full Story  |  1 Comment
Tagged with: , ,

STA-9090 highly promising in advanced gastrointestinal stromal tumours (GIST), says Synta

Wednesday, December 30, 2009 12:20

STA-9090, an experimental treatment against advanced gastrointestinal stromal tumours (GIST) has been shown encouraging results, according to Synta Pharmaceuticals Corp.

This was posted under category: Pharma  |  Read Full Story  |  0 Comments
Tagged with:

Ceftobiprole antibiotic to fight tougher bacterial infections fails to win approval in US

Wednesday, December 30, 2009 11:25

Ceftobiprole, a new antibiotic from Basilea Pharmaceutica to treat the tougher bugs like MSRA-resistant bacteria, has been rejected by USFDA.

This was posted under category: Clinical Trials  |  Read Full Story  |  1 Comment
Tagged with: